Company context

Vertex Pharmaceuticals Incorporated

NASDAQ:VRTX

Pharmaceuticals: Major · benchmarked against Pharmaceuticals: Major inside the XLV constituent company universe.

Active tabPeers

Current readMixed

Last close473.08

1M return-10.67%

OverviewVerdict, thesis map, and valuation setup.FundamentalsDrivers, trajectory, and business quality.Financial reportsStatement tables, sorting, filtering, and acceleration.Ex-ante forecastTarget price, dividend yield, and total return by horizon.FactorsCompany factor exposure, rank, and universe context.Market viewMomentum, catalysts, charts, and symbol packet.AttributionLarge-move causes, residuals, and research backlog.OwnershipSEC 13F holder flow, crowding, and manager changes.PeersPeer heatmap and closest comparables.

Tab scope

Relative comparables

Peers

Source and lookbackPeer fundamentals and stored return summaries5101 stored daily bars; peer return rows use each peer's stored price summary where available.

Sample and caveat12 closest comparables from industry, sector, and market peer pools.Use this tab for its stated job; heavier model packets stay on their own tabs.

Peer return matrix

Cumulative returns across peer horizons

Stored daily closes, when available

NASDAQ:VRTX 1W -2.66%, 1M -10.67%, 3M +8.93%, 6M -1.01%, 1Y +17.98%, 3Y +34.55%; NASDAQ:REGN 1W -3.94%, 1M +0.36%, 3M +3.47%, 6M -17.19%, 1Y +12.85%, 3Y -21.51%; NASDAQ:INCY 1W -0.16%, 1M +0.73%, 3M +21.82%, 6M +17.80%, 1Y +35.45%, 3Y +79.64%; NASDAQ:BIIB 1W -4.75%, 1M -4.54%, 3M +4.42%, 6M +4.76%, 1Y +42.51%, 3Y -24.92%; NYSE:JNJ 1W +2.02%, 1M -1.66%, 3M +10.88%, 6M +3.96%, 1Y +43.22%, 3Y +55.23%; NYSE:MRK 1W +0.20%, 1M +0.87%, 3M +11.94%, 6M +6.32%, 1Y +49.60%, 3Y +17.40%; NYSE:ZTS 1W -4.08%, 1M -2.19%, 3M -6.53%, 6M -41.43%, 1Y -51.75%, 3Y -60.55%; NYSE:LLY 1W -0.61%, 1M -3.17%, 3M +13.76%, 6M +15.79%, 1Y +58.05%, 3Y +109.78%; NYSE:PFE 1W -1.27%, 1M +4.64%, 3M -3.27%, 6M -6.76%, 1Y -0.64%, 3Y -31.46%; NYSE:BMY 1W +0.38%, 1M +7.13%, 3M +4.17%, 6M -2.55%, 1Y +28.12%, 3Y -1.46%; NASDAQ:VTRS 1W -1.53%, 1M +1.58%, 3M +5.53%, 6M +16.01%, 1Y +61.60%, 3Y +55.70%

Company1W1M3M

6M

1Y

3Y

NASDAQ:VRTX-2.66%-10.67%+8.93%-1.01%+17.98%+34.55%

NASDAQ:REGN-3.94%+0.36%+3.47%-17.19%+12.85%-21.51%

NASDAQ:INCY-0.16%+0.73%+21.82%+17.80%+35.45%+79.64%

NASDAQ:BIIB-4.75%-4.54%+4.42%+4.76%+42.51%-24.92%

NYSE:JNJ+2.02%-1.66%+10.88%+3.96%+43.22%+55.23%

NYSE:MRK+0.20%+0.87%+11.94%+6.32%+49.60%+17.40%

NYSE:ZTS-4.08%-2.19%-6.53%-41.43%-51.75%-60.55%

NYSE:LLY-0.61%-3.17%+13.76%+15.79%+58.05%+109.78%

NYSE:PFE-1.27%+4.64%-3.27%-6.76%-0.64%-31.46%

NYSE:BMY+0.38%+7.13%+4.17%-2.55%+28.12%-1.46%

NASDAQ:VTRS-1.53%+1.58%+5.53%+16.01%+61.60%+55.70%

Peer scorecard analytics

Different ways to compare this peer set

11 companies including target

Return leadership

NASDAQ:VTRS+61.60% 1Y · +55.70% 3Y

NYSE:LLY+58.05% 1Y · +109.78% 3Y

NYSE:MRK+49.60% 1Y · +17.40% 3Y

NYSE:JNJ+43.22% 1Y · +55.23% 3Y

Risk and quality spread

NYSE:LLYGM +82.83% · ROE +107.64%

NYSE:JNJGM +75.08% · ROE n/a

NYSE:ZTSGM +70.43% · ROE +67.01%

NASDAQ:INCYGM +91.22% · ROE +30.82%

Valuation screen

NYSE:ZTSP/E 12.48 · FCF yield +6.76%

NASDAQ:REGNP/E 16.45 · FCF yield +5.81%

NASDAQ:INCYP/E 16.60 · FCF yield +6.19%

NYSE:BMYP/E 17.10 · FCF yield +9.57%

Valuation versus growth

P/E against 1Y return

NASDAQ:VRTX P/E 28.57 1Y +17.98%, NASDAQ:REGN P/E 16.45 1Y +12.85%, NASDAQ:INCY P/E 16.60 1Y +35.45%, NASDAQ:BIIB P/E 21.80 1Y +42.51%, NYSE:JNJ P/E 29.05 1Y +43.22%, NYSE:MRK P/E 35.53 1Y +49.60%, NYSE:ZTS P/E 12.48 1Y -51.75%, NYSE:LLY P/E 42.31 1Y +58.05%, NYSE:PFE P/E 19.12 1Y -0.64%, NYSE:BMY P/E 17.10 1Y +28.12%, NASDAQ:VTRS P/E n/a 1Y +61.60%

Peer heatmap

Where this company wins and lags

12 stored peers

CompanyP/E TTMPrice / SalesFCF yieldGross marginReturn on equityDebt / Equity

NASDAQ:VRTXVertex Pharmaceuticals Incorporated

28.5745th pctile9.9817th pctile+3.03%18th pctile+86.38%92nd pctile+24.20%60th pctile0.1080th pctile

NASDAQ:REGNRegeneron Pharmaceuticals, Inc.

16.4586th pctile4.8543rd pctile+5.81%50th pctile+80.93%57th pctile+14.55%17th pctile0.0983rd pctile

NASDAQ:INCYIncyte Corporation

16.6071st pctile4.4671st pctile+6.19%67th pctile+91.22%100th pctile+30.82%67th pctile0.01100th pctile

NASDAQ:BIIBBiogen Inc.

21.8057th pctile3.09100th pctile+8.08%100th pctile+66.29%0th pctile+7.70%0th pctile0.3550th pctile

NYSE:JNJJohnson & Johnson

29.0529th pctile6.2029th pctilen/an/a+75.08%43rd pctilen/an/an/an/a

NYSE:MRKMerck & Company, Inc.

35.5314th pctile4.6957th pctile+4.53%33rd pctile+73.44%29th pctile+18.97%33rd pctile1.0733rd pctile

NYSE:ZTSZoetis Inc.

12.48100th pctile3.3886th pctile+6.76%83rd pctile+70.43%14th pctile+67.01%83rd pctile2.860th pctile

NYSE:LLYEli Lilly and Company

42.310th pctile14.220th pctile+1.07%0th pctile+82.83%71st pctile+107.64%100th pctile1.3917th pctile

Color ranks each metric in the favorable direction, so lower leverage and cheaper multiples can still score green.